Cargando…

Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

BACKGROUND & AIMS: Alcohol is the most common cause of liver-related mortality and morbidity. We therefore aimed to assess and compare the prognostic performance of elastography and blood-based markers to predict time to the first liver-related event, severe infection, and all-cause mortality in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasmussen, Ditlev Nytoft, Thiele, Maja, Johansen, Stine, Kjærgaard, Maria, Lindvig, Katrine Prier, Israelsen, Mads, Antonsen, Steen, Detlefsen, Sönke, Krag, Aleksander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522804/ https://www.ncbi.nlm.nih.gov/pubmed/34118335 http://dx.doi.org/10.1016/j.jhep.2021.05.037

Ejemplares similares

Serum keratin‐18 detects hepatic inflammation and predicts progression in compensated alcohol‐associated liver disease
por: Thorhauge, Katrine Holtz, et al.
Publicado: (2022)

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
por: Israelsen, Mads, et al.
Publicado: (2023)

Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
por: Kjaergaard, Maria, et al.
Publicado: (2022)

Noninvasive proteomic biomarkers for alcohol-related liver disease
por: Niu, Lili, et al.
Publicado: (2022)

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)

Alcoholic liver disease: A registry view on comorbidities and disease prediction
por: Grissa, Dhouha, et al.
Publicado: (2020)

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation
por: Thiele, Maja, et al.
Publicado: (2021)

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial
por: Madsen, Bjørn Stæhr, et al.
Publicado: (2018)

Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care
por: Blanes-Vidal, Victoria, et al.
Publicado: (2022)

PRO‐C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol‐related liver disease
por: Madsen, Bjørn S., et al.
Publicado: (2021)

Ketamine as an Anesthetic for Patients with Acute Brain Injury: A Systematic Review
por: Gregers, Mads Christian Tofte, et al.
Publicado: (2020)

Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication
por: Israelsen, Mads, et al.
Publicado: (2021)

High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal
por: Kjærgaard, Maria, et al.
Publicado: (2017)

IgG4-Related Sclerosing Cholangitis Involving the Intrahepatic Bile Ducts Diagnosed with Liver Biopsy
por: Thinesen, Malene Theilmann, et al.
Publicado: (2018)

A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease
por: Åberg, Fredrik, et al.
Publicado: (2021)

Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease
por: Hagström, Hannes, et al.
Publicado: (2022)

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness
por: Indira Chandran, Vineesh, et al.
Publicado: (2023)

Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury
por: Terkelsen, Mike K., et al.
Publicado: (2020)

Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
por: Torp, Nikolaj, et al.
Publicado: (2021)

Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
por: Torp, Nikolaj, et al.
Publicado: (2021)

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease
por: Tyc, Olaf, et al.
Publicado: (2020)

Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease
por: Trebicka, Jonel, et al.
Publicado: (2022)

Bacteremic patients in the Emergency Department – how do they present and what is the diagnostic validity of temperature, CRP and SIRS?
por: Lindvig, Katrine Prier, et al.
Publicado: (2013)

Are Nonalcoholic Fatty Liver Disease and Bone Mineral Density Associated? — A Cross‐Sectional Study Using Liver Biopsy and Dual‐Energy X‐Ray Absorptiometry
por: Hansen, Stinus Gadegaard, et al.
Publicado: (2023)

Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis
por: Thiele, Maja, et al.
Publicado: (2013)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts: Medium-Term Assessment of Outcomes and Complications
por: Ng, Pui Yung, et al.
Publicado: (2013)

Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications
por: Elshaarawy, Omar, et al.
Publicado: (2019)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

LIVER BIOPSY
Publicado: (1962)

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
por: Graupera, Isabel, et al.
Publicado: (2022)

Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis
por: Spahr, Laurent, et al.
Publicado: (2011)

Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
por: Angelini, Giulia, et al.
Publicado: (2023)

Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
por: Graupera, Isabel, et al.
Publicado: (2023)

How do bacteraemic patients present to the emergency department and what is the diagnostic validity of the clinical parameters; temperature, C-reactive protein and systemic inflammatory response syndrome?
por: Lindvig, Katrine Prier, et al.
Publicado: (2014)

Large Variations in Risk of Hepatocellular Carcinoma and Mortality in Treatment Naïve Hepatitis B Patients: Systematic Review with Meta-Analyses
por: Thiele, Maja, et al.
Publicado: (2014)

Assessment of biopsy‐proven liver fibrosis by two‐dimensional shear wave elastography: An individual patient data‐based meta‐analysis
por: Herrmann, Eva, et al.
Publicado: (2017)

Accuracy and clinical outcomes of pancreatic EUS-guided fine-needle biopsy in a consecutive series of 852 specimens
por: Thomsen, Mikkel Marschall, et al.
Publicado: (2022)

A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)
por: Rasmussen, Louise Skau, et al.
Publicado: (2023)

LIVER BIOPSY INTERPRETATION
Publicado: (1973)

Cannot write session to /tmp/vufind_sessions/sess_9atqtor5lhs4vhvobbs2p5a9ts